Top compounds associated with response to MYLPF


Feature Type Standardized
Nominal ANOVA
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.075 0.01
mRNA GSK269962A GDSC1000 pan-cancer AAC -0.08 0.02
mRNA PD-0332991 GDSC1000 pan-cancer AAC -0.084 0.02
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.075 0.02
mRNA BRD-K29086754 CTRPv2 pan-cancer AAC 0.38 0.02
mRNA MLN4924 GDSC1000 pan-cancer AAC -0.093 0.02
mRNA Sunitinib FIMM pan-cancer AAC -0.4 0.02
mRNA Vinblastine GDSC1000 pan-cancer AAC -0.077 0.03
mRNA Gemcitabine gCSI pan-cancer AAC -0.13 0.03
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.075 0.03
Download CSV